Claudia Mazzà

Indivi is a leading Medtech for the development of digital measurements > biomarkers in neuroscience, headquartered in Basel, Switzerland. Indivi is committed to developing and validating transformative digital endpoints to accelerate and de-risk drug development in neurodegenerative diseases, with a focus on multiple sclerosis, Parkinson’s and Alzheimer’s diseases. Through its exclusive partnership with Basel University Faculty of Medicine and the Research Center for Clinical Neuroimmunology and Neuroscience in Basel (RC2NB), Indivi is dedicated to unlocking the potential of digital endpoints and precision medicine in drug development by creating a fertile symbiotic intersection of knowledge in Data Science, Clinical Science and Advanced Analytics (including machine learning and so-called artificial intelligence).